About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 2NCT00110487

Study Evaluating ERB-041 in Endometriosis in Reproductive-Age Women

The purpose of this investigational study is to determine if a study medication is safe and effective in reducing the symptoms associated with endometriosis; if the study medication reduces the need f...

Lead sponsor: Wyeth is now a wholly owned subsidiary of Pfizer•46 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer

Age

18 - 45 years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Surgical diagnosis of endometriosis within 5 years
•Not pregnant and not lactating
•Willing to use non-hormonal contraception, history of regular menstrual cycles

Exclusion Criteria

•Hysterectomy, surgical treatment for endometriosis within 3 months
•Certain medications for the treatment of endometriosis
•Previous history of a malignancy
•Abnormalities on physical or gyn exams and abnormal lab tests

Related studies

Study on the Outcomes of Patients Treated in Gynecological Emergency Departments for Pelvic Endometriosis or Suspected Pelvic Endometriosis

NCT07472842 · Endometriosis, Pelvic Pain Syndrome, and more

Pesticides and Infertility: Oxidative Stress Via Circulating Cell-free DNA and Gut/Genital Microbiome Signatures in Women With Endometriosis

NCT07471373 · Endometriosis, Infertility, and more

The Developmental Origins of Endometriosis

NCT05951452 · Endometriosis

RECRUITINGPhase 2

Glycemic Regulation as Endometriosis Adjunct Treatment

NCT06611501 · Pelvic Pain, Endometriosis

RECRUITINGPhase 3

Estradiol-mediated Inflammation and Central Sensitization in the Pathophysiology of Endometriosis-associated Pelvic Pain

NCT07100782 · Endometriosis, Pelvic Pain

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 1, 2015Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment200

Start dateJan 2005

Last updatedMay 1, 2015

Condition

Locations shown

Phoenix, Arizona

Tucson, Arizona

Carmichael, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 1, 2015Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions